Herophilus is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.09.2018 | Series A | $25M | - |
Mentions in press and media 7
| Date | Title | Description |
| 14.09.2018 | Term Sheet — Friday, September 14 | BORING IS THE NEW BLACK
Good morning, Term Sheet readers.
Paid Content How can you protect what you can't see? From ExtraHop
BORING IS GOOD? I can’t stop thinking about this NYT story by Farhad Manjoo, in which he explores the notion that i... |
| 13.09.2018 | Daily funding roundup - September 13th, 2018 | Applied Intuition has raised $11.5M; HYP3R raised $17M; Coda Biotherapeutics raised $19M
Singularity 6: Singularity 6 explores new styles of game design and tackling difficult technical problems to create worlds that are beautiful and intri... |
| 13.09.2018 | System1 Biosciences raises $25M in Series A round for neurotherapeutics discovery platform | The company plans to use the money to fund its drug-discovery programs, which are focused on epilepsy, autism and schizophrenia.
System1’s platform involves of using stem cell lines from patients with brain diseases to create cerebral organ... |
| 12.09.2018 | System1 Announces $25 Million Series A Funding | - |
| 12.09.2018 | System1 Biosciences Secures $25M Series A |
SAN FRANCISCO, CA, Neurotherapeutics company announced the completion of $25 million in Series A financing.
>> Click here for more funding data on System1 Biosciences
>> To export System1 Biosciences funding data to PDF and ... |
| 12.09.2018 | System1 Raises $25M in Series A Funding | System1 Biosciences, Inc., a San Francisco, CA-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for neurological and psychiatric disorders, completed a $25m Series A financing.
The round was co-led b... |
| - | System1 Biosciences raises $25M in Series A round for neurotherapeutics discovery platform | A West Coast startup has raised a venture capital funding round for its psychiatric and neurological drug-discovery platform.
San Francisco-based System1 Biosciences said Wednesday that it had raised $25 million in a Series A financing roun... |
Reviews 0
